Law360, New York (August 26, 2008, 12:00 AM EDT) -- A federal judge has refused to throw out three antitrust class actions accusing Barr Pharmaceuticals Inc. of accepting a $20 million payment in exchange for keeping a generic version of oral contraceptive Ovcon off the market, thereby inflating the price of the drug.
In an opinion dated Aug. 11 and made public Tuesday, Judge Colleen Kollar-Kotelly of the U.S. District Court for the District of Columbia denied the majority of the pharmaceutical company's motion for summary judgment, ruling that the case hinges on the proper definition...
Barr Still On The Hook In Ovcon Antitrust Suit
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
